Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2007;62:3-4; doi:10.1136/thx.2005.051011
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society.

EDITORIAL

Cryptogenic fibrosing alveolitis

What is this thing called CFA?

A U Wells, D M Hansell, A G Nicholson

Royal Brompton Hospital, London, UK

Correspondence to:
Correspondence to:
Dr A U Wells
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; a.wells@rbh.nthames.nhs.uk


The term "cryptogenic fibrosing alveolitis"should now be used as strictly synonymous with "idiopathic pulmonary fibrosis"

The first 150 words of the full text of this article appear below.

Arcane diagnostic labels bother clinicians. The diffuse lung disease lexicon is a notorious example. For decades, "diffuse lung disease speak" consisted of an unholy mix of histopathological and clinical terms, varying between countries, within countries and even between medical teams in the same hospital. Radical change was required and proposals were advanced in a joint American Thoracic Society and European Respiratory Society (ATS/ERS) initiative. Terminology for idiopathic interstitial pneumonia was distilled by a core group of clinicians, radiologists and pathologists, and this was then circulated to a larger group of international reviewers and published in 2002.1 The final consensus classification was not, at first sight, straightforward to apply. Indeed, the amorphous entity of "non-specific interstitial pneumonia" (NSIP) continues to vex clinicians and requires further subclassification. However, teething problems aside, the ATS/ERS initiative has been an outstanding success. Clinicians and researchers worldwide now understand each other better than . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis
Gavin Barlow, Dilip Nathwani, Fiona Williams, Simon Ogston, John Winter, Michael Jones, Peter Slane, Elizabeth Myers, Frank Sullivan, Nicola Stevens, Rebecca Duffey, Karen Lowden, and Peter Davey
Thorax 2007 62: 67-74. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Wells, A U, Hirani, N, on behalf of the BTS Interstitial Lung Disease Gui, (2008). Interstitial lung disease guideline. Thorax 63: v1-v58 [Full Text]  
  • Wells, A. U., Hogaboam, C. M. (2008). Update in Diffuse Parenchymal Lung Disease 2007. Am. J. Respir. Crit. Care Med. 177: 580-584 [Full Text]  
  • Nicholson, A. G., Bush, A. (2007). Classification of Diffuse Lung Disease in Infants: The Reality of Groups. Am. J. Respir. Crit. Care Med. 176: 1060-1061 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs